IDEAYA Biosciences (IDYA) Reports Q4 Loss of $0.18/sh
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Join SI Premium – FREE
IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.18), versus ($0.53) reported last year. Revenue for the quarter came in at $10.57 million, versus $0 reported last year.
For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc. (XP) Tops Q2 EPS by 8c
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
